Medicare Enrolled

Dr. Christina Gutierrez-Steil, MD

Dermatology · Hinsdale, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
125 W 2ND ST, Hinsdale, IL 60521
6304550045
In practice since 2006 (20 years)
NPI: 1588616288 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gutierrez-Steil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutierrez-Steil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gutierrez-Steil

Dr. Christina Gutierrez-Steil is a dermatology specialist in Hinsdale, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gutierrez-Steil performed 11,961 Medicare services across 1,170 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gutierrez-Steil received a total of $6,550 from 34 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gutierrez-Steil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in IL $6,550 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,961
Medicare services
Top 3% in IL for dermatology
1,170
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~598 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 10,400 $1 $2
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
351 $5 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
261 $67 $156
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
251 $29 $122
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
203 $42 $180
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
143 $90 $229
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
78 $78 $233
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
45 $81 $266
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
43 $73 $246
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
33 $94 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $118 $355
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
28 $102 $314
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $44 $94
Shaving of small skin growth on face or mouth area
A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth.
18 $88 $252
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
18 $239 $654
Skin growth shaving, 0.5 cm or less
This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs.
16 $54 $217
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
16 $108 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,550
Total received (2018-2024)
Avg $936/year across 7 years
Top 28% in IL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,340 (51.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,091 (47.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$119 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$394
2023
$656
2022
$243
2021
$179
2020
$57
2019
$1,020
2018
$4,001

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$135
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Galderma Laboratories, L.P.
$42
Verrica Pharmaceuticals Inc.
$40
Biofrontera Inc.
$37
MERZ NORTH AMERICA, INC.
$36
Lilly USA, LLC
$23
PFIZER INC.
$20
Ortho Dermatologics, a division of Bausch Health US, LLC
$16
Top 3 companies account for 56.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,141
ABBVIE INC.
$472
Ortho Dermatologics, a division of Bausch Health US, LLC
$443
Galderma Laboratories, L.P.
$326
Novartis Pharmaceuticals Corporation
$304
AbbVie, Inc.
$251
GENZYME CORPORATION
$201
Mayne Pharma Inc.
$165
Merz North America, Inc.
$152
Biofrontera Inc.
$138
Janssen Biotech, Inc.
$119
LEO Pharma Inc.
$106
PFIZER INC.
$69
Bayer HealthCare Pharmaceuticals Inc.
$65
Incyte Corporation
$55
Lilly USA, LLC
$49
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Sun Pharmaceutical Industries Inc.
$42
Allergan, Inc.
$41
Verrica Pharmaceuticals Inc.
$40
Encore Dermatology Inc.
$40
EPI Health, LLC
$39
Mission Pharmacal Company
$39
MERZ NORTH AMERICA, INC.
$36
DERMIRA, INC.
$27
Celgene Corporation
$25
MAYNE PHARMA COMMERCIAL LLC
$24
Almirall LLC
$24
Allergan Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
Sensus Healthcare, Inc.
$14
Glenmark Therapeutics Inc.
$10
PruGen, Inc. Pharmaceuticals
$10
Musculoskeletal Transplant Foundation Inc.
$9
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
ABSORICA · AKLIEF · ALTRENO · AMELUZ · Ameluz · Avar · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · FINACEA · Finacea · Humira · Impoyz · Mupirocin Cream · OPZELURA · ORACEA · Ovace · REMICADE · RETIN-A-MICRO · SKYRIZI · SOOLANTRA · Seysara · TALTZ · TREMFYA · VALCHLOR · Winlevi · XEOMIN · Xeomin · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Hinsdale?
Compare dermatologists in the Hinsdale area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
401
Per 100K population
43.2
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gutierrez-Steil is a mixed practice specialist, with above-average Medicare volume (top 3% in IL), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gutierrez-Steil experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Gutierrez-Steil performed 10,400 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gutierrez-Steil receive payments from pharmaceutical companies?
Yes. Dr. Gutierrez-Steil received a total of $6,550 from 34 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutierrez-Steil's costs compare to other dermatologists in Hinsdale?
Dr. Gutierrez-Steil's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutierrez-Steil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →